Gasgon Medical

What Gasgon Medical does

Gasgon Medical is a Cork, Ireland-based medical device startup (legally Tessen Solutions Ltd t/a Gasgon Medical) founded by Vincent Forde in 2016, developing AirVault® — a patented, single-use, closed-system device that captures and removes air bubbles from IV fluids during infusion administration. The product addresses a high-frequency clinical problem: more than 80% of hospital patients receive IV medicine, and air-in-line events cause alarm fatigue, maintenance delays, hazardous drug exposure risk, and potential vascular air embolism. AirVault® is targeted at hospitals, cancer and oncology centers, home infusion providers, and specialty care settings including pediatrics, cardiology, and intensive care. The company is pre-revenue, with US commercialization pending 510(k) clearance and EU launch contingent on CE marking.

The company's technology is protected by a broad international IP portfolio including granted US Patent No. 12,239,773, granted patents in China (ZL201980090735.9), Europe (3917643), and Japan (7321276), the registered AirVault® trademark, six EU design registrations, and multiple pending applications across the US, EU, China, Japan, Israel, and two PCT filings. Clinical validation is in progress through the €3 million EU-funded Swirl SAFE-infusion consortium with Tada Medical and Remote Signals, including hospital trials at Centro Hospitalar e Universitário de Coimbra (CHUC, Portugal) and Parc Sanitari Sant Joan de Déu (PSSJD, Spain). The company is supported by Enterprise Ireland, EIT Health, the European Innovation Council, Health Innovation Hub Ireland, and Cork County Council, and has accumulated numerous awards including the 2023 NHIA Innovation Award, 2023 National Startup Awards Gold in Medtech, 2021 InterTradeIreland Seedcorn overall winner, and 2nd place at the 2019 EIT Health European Health Catapult.

Gasgon Medical operates a consumable-based revenue model via single-use IV safety device sales to enterprise healthcare providers, with go-to-market executed through direct enterprise field sales and channel support from Enterprise Ireland. The team of 1-10 employees includes a CFO (Dan Stapleton), CTO (Pauric Carey, 10+ years Class I-III medical device experience), Lead Design Engineer (James Roche, ISO 13485 expertise), and a Clinical Advisory Board of infusion nursing and respiratory therapy experts. Total funding to date is approximately €2.25 million in equity from a 2022 seed round led by Furthr VC (with Enterprise Ireland, HBAN, and Irrus Investments) plus the €3 million EIC grant and roughly €150,000 in cumulative prize money. Pricing is not publicly disclosed, the product is not yet available for sale in the US, and the company is positioning for sequential EU and US market entry.

Name

Gasgon Medical

Legal name

Tessen Solutions Ltd t/a Gasgon Medical

Website

https://gasgonmedical.com

Company type

Private

Founded year

2016

Operating status

Operating

Headcount range

1–10 employees

Short description

Gasgon Medical is a Cork, Ireland-based medical device startup developing AirVault®, a patented single-use device that removes air bubbles from IV infusions. The pre-revenue company targets hospitals, home infusion providers, and specialty care markets across the EU and US.

Ownership category

akta.pro rank

Product category

Medical Devices - IV Infusion Safety

akta.pro industry

PRIMARYHLAHAGAK

Anesthesia & Respiratory Gas Delivery Equipment (Breathing Circuits, Vaporizers, Gas Mixers)

Healthcare & Life Sciences/Medical Devices & Diagnostics/Respiratory & Sleep Therapy Devices

Keywords

• IV infusion safety
• Air bubble removal
• Single-use medical devices
• Fluid management devices
• Infusion therapy accessories

Headquarters

HQ city

Carrigaline

HQ country

Ireland

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Technology or R&D, Supply Chain, Operations, Marketing or Sales

Revenue model

1. Medical Device Sales: Pre-revenue medical device company preparing to launch its first range of products. AirVault® is a single-use device indicating a consumable/repeat purchase revenue model once commercialized.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Core offering

Gasgon Medical is a medical device company developing and commercializing AirVault®, a patented single-use device designed to capture and remove air bubbles from IV fluids during infusion administration. The product is intended for hospitals, cancer centers, infusion centers, and home infusion providers to reduce IV delivery alarms, maintenance delays, and patient safety risks including vascular air embolism. The company is pre-revenue and preparing for its first commercial launch in the EU, with US market entry pending 510(k) FDA clearance.

Product overview

Gasgon Medical offers a single core product, AirVault®, a single-use IV safety device that removes air bubbles from IV fluids during infusion administration. The company is an award-winning medical device startup preparing to launch its first product range in the clinical market, with a focus on fluid management solutions for IV infusions.

Differentiator

Problem solved

Functional benefit

Brands

• AirVault®: A patented single-use medical device to remove air bubbles from IV fluids during administration. A closed-system air trap that proactively removes air in line.

Products and services

• AirVault® AirVault® is a patented single-use medical device designed to capture and remove air bubbles from IV fluids during infusion administration. It is intended for hospitals, cancer centers, infusion centers, and home infusion providers to reduce IV delivery alarms, maintenance delays, and patient safety risks including vascular air embolism.

Quantifiable outcome

• AirVault® selected as overall winner at National Home Infusion Awards (NHIA) 2023, recognized as 'game-changing' infusion industry product by expert clinician panel
• +2 more outcomes

Named customers8 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Partnerships

Ten partnerships are on record, tiered core and minor.

• Tada MedicalcoreStrategic or Co-development Partner · 21 May 2021Two-year Swirl SAFE-infusion project awarded €3 million from European Innovation Council. Joint collaboration to improve safety of IV infusions for patients and care providers. Collaboration examining how shifting IV therapy from hospital to home will affect risk management for vascular air embolism and IV line dislodgement.
• EIT HealthcoreGTM or Marketing PartnerEIT Health supported Gasgon Medical with €50,000 Headstart Funding Programme 2018, selected for European Health Catapult competition, participated in InterTradeIreland Seedcorn. EIT Health is a European health innovation network providing acceleration and market access support.
• HealthInnovationHubIreland (HIHI)minorGTM or Marketing PartnerSelected for acceleration within Irish healthcare system. Listed among 20 Irish companies disrupting health-tech sector. HIHI Open Call promotion including CTO interview for innovation brochure.
• Centro Hospitalar e Universitário de Coimbra (CHUC)coreStrategic or Co-development PartnerWorking with clinical team at CHUC, a leading healthcare institute in Portugal, for SAFE-Infusion project. Project selected by CHUC to further their commitment to improving patient safety and healthcare performance through IV device development.
• Parc Sanitari Sant Joan de Déu (PSSJD) / Fundació Sant Joan de Déu (FSJD)coreStrategic or Co-development PartnerCollaborating with leading Barcelona research foundation to prepare IV infusion devices for launch. Clinical team at PSSJD committed to improving safety and clinical outcomes with strong potential identified in Gasgon's technology.
• European Federation of Nurses (EFN)minorStrategic or Co-development PartnerMet with Secretary General Paul De Raeve in Brussels to discuss important role EFN plays advocating for its 3 million nurse members across EU and wider role MedTech innovation can play to reduce burden of care at bedside.
• Remote SignalsminorStrategic or Co-development PartnerPart of Swirl SAFE-infusion consortium alongside Tada Medical to determine if technology can be used to improve infusion of IV drugs.
• Cork County CouncilminorGTM or Marketing PartnerSelected for Cork County Council national campaign to travel to Boston as one of twelve Irish MedTech and LifeScience startups.
• Voisin Consulting - Neighborhood ProgramminorImplementation/ SI/ Consulting PartnerJoined prestigious Paris-based Neighborhood program delivered by Voisin Consulting to support regulatory journey ahead of planned EU launch.
• ACTION Innovation Network - InterACTION ProgramminorGTM or Marketing PartnerSelected for InterACTION Healthcare 2020 program as one of 5 companies from international cohort with focus on Boston and New England region for US market entry. Program delivered mentoring on FDA regulatory pathway, legal frameworks, investment and sales strategy.

Scale indicators6 records

Recent moves6 records

Expansion highlights7 records

Direct peers

• Elcam Medical: Israeli OEM/ODM manufacturer of single-use IV components and fluid-management devices used by global IV therapy brands. Comparable in scale and product type for IV consumables including air-handling and fluid path components.
• Tada Medical: Ireland-based IV drug delivery safety device company and Gasgon's co-development partner in the €3M EIC-funded Swirl SAFE-infusion project. Operates in the same IV air-in-line and infusion-safety niche with similar problem framing.
• Vygon: French-headquartered single-use IV catheter and accessory manufacturer. Operates in the same single-use IV consumable category with overlapping hospital customers in Europe and similar product economics.
• Smiths Medical: Manufacturer of IV infusion pumps and accessories (acquired by ICU Medical in 2022). Sells air-eliminating filters and IV sets directly competitive with the AirVault® use case, and bundles accessories with installed pump bases.

Broad incumbents

• ICU Medical: US-listed pure-play IV therapy company making IV pumps, sets, and accessories including air-eliminating filters. Operates the same hospital IV consumable market as Gasgon but across a much broader portfolio, and has acquired Smiths Medical.
• Baxter International: Global leader in IV solutions, infusion pumps, and IV administration sets. Sells through hospital formularies where AirVault® would need to be adopted, and controls pump architectures that determine whether accessory devices can attach.
• Becton, Dickinson and Company (BD): Diversified medical device conglomerate with a large IV therapy and infusion portfolio. BD's scale and contracts make it the dominant gatekeeper for IV consumable adoption in many hospital systems where Gasgon would sell.
• B. Braun Melsungen: German medical technology major with a strong IV therapy and infusion systems portfolio (Infusomat, Perfusor). Competes for the same IV administration set budgets and could integrate air-in-line mitigation directly into its consumable lines.
• Fresenius Kabi: Global IV solutions, infusion pumps, and clinical nutrition provider. Sells complete IV therapy stacks into hospitals — the same customers Gasgon would approach — and could easily extend into air-in-line accessories.
• Teleflex: Diversified medical device company with a vascular access and IV therapy portfolio. Operates in the same hospital procurement channels and offers competing single-use IV accessories at large scale.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks7 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/gasgon-medical
• Xtwitter.com/GasgonM

Revenue estimate

Valuation estimate

Number of profiles

Profiles11 records

Funding overview

Funding rounds3 records

Investors6 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Gasgon Medical